SLC7A11 and Hepatic fibrosis: In both in vivo and in vitro studies, mesenchymal stem cell-derived exosomal miR-26a was shown to inhibit HSCs activation by downregulating SLC7A11 expression, thereby promoting ferroptosis in HSCs and mitigating liver fibrosis (Cao et al., 2024).